Fresenius Medical Care AG & Co. KGaA (FMS) は上場企業です ヘルスケア セクターの Medical - Care Facilities 業界で事業展開. 本社所在地は Bad Homburg, ドイツ. 現CEOは Helen Giza.
FMS を有する IPO日 1996-09-17, 112,035 名の正社員, に上場 NYSE, 時価総額 $13.38B.
Fresenius Medical Care AG & Co. KGaA is a global leader in dialysis care and renal disease treatment, operating approximately 4,171 outpatient dialysis clinics across 150 countries. The company provides comprehensive dialysis services including treatment delivery, laboratory diagnostics, patient support, and clinical monitoring, alongside specialized services for hospitalized end-stage renal disease patients and those with acute kidney failure. It manufactures and distributes a broad portfolio of dialysis products such as dialyzers, hemodialysis machines, peritoneal dialysis solutions, and water treatment systems, as well as renal pharmaceuticals and non-dialysis products including cardiopulmonary and apheresis solutions. Additionally, the company offers vascular care, cardiovascular services, and physician nephrology and cardiology services through ambulatory surgery centers. Headquartered in Bad Homburg, Germany, Fresenius Medical Care distributes its products through direct sales channels, independent distributors, and dealers to dialysis clinics, hospitals, and specialized treatment facilities worldwide.
